‘Obsolete, Misguided’: Critics Call Out Pfizer’s Plan for Bivalent Booster for Kids Under 5

Children’s Health Defense Article by Michael Nevradakis, Ph.D.

“Pfizer and BioNTech said Monday they are seeking Emergency Use Authorization for an updated COVID-19 bivalent booster vaccine for children ages 6 months to 4 years old, but critics said the vaccines are obsolete and too risky.

Article by Michael Nevradakis, Ph.D.

Pfizer on Monday said if the bivalent booster receives EUA, children in this age group will receive two doses of the original COVID-19 vaccine, followed by a dose of the “updated” vaccine targeting Omicron subvariants BA.4 and BA.5.

Previously, children under age 5 could receive a three-dose series of the original COVID-19 vaccine. However, since the shots received EUA in June, only 2% of children under 2 and about 4% of 2- to 4-year-olds have received their primary doses, according to the Centers for Disease Control and Prevention (CDC).

The bivalent vaccine is currently authorized as a “booster” dose in the U.S. and the EU, for children 5 and older.

Bivalent boosters are ‘obsolete,’ come with ‘very concerning side effects’”

Read the full article free, with quotes from Dr. Meryl Nass, Dr. Peter McCullough, and Michelle Perro